These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8255684)

  • 41. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.
    Couser RJ; Ferrara TB; Ebert J; Hoekstra RE; Fangman JJ
    J Pediatr; 1990 Jan; 116(1):119-24. PubMed ID: 2404097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
    Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
    [No Abstract]   [Full Text] [Related]  

  • 43. Results of laboratory surveillance of very low birth weight infants treated with a synthetic surfactant.
    Bose C; Corbet A; Bose G; Prats JG; Russell L; Edwards K
    J Pediatr; 1992 Feb; 120(2 Pt 2):S13-7. PubMed ID: 1735845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retinopathy of prematurity in infants less than 29 weeks' gestation: 3 1/2 years pre- and postsurfactant.
    Kennedy J; Todd DA; Watts J; John E
    J Pediatr Ophthalmol Strabismus; 1997; 34(5):289-92. PubMed ID: 9310917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of the acute response to surfactant therapy by pulmonary function testing.
    Wallenbrock MA; Sekar KC; Toubas PL
    Pediatr Pulmonol; 1992 May; 13(1):11-5. PubMed ID: 1589306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repeated doses of the perfluorocarbon FC-100 improve lung function of preterm lambs.
    Moya FR; Llanos AJ; Ríos AM; Riquelme RA; Moraga FA; Rubio LA; Salvo HD; Jacobs HC
    Pediatr Res; 1997 Dec; 42(6):893-8. PubMed ID: 9396575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets.
    Sood SL; Balaraman V; Finn KC; Wilkerson SY; Mundie TG; Easa D
    Pediatr Pulmonol; 1996 Dec; 22(6):376-86. PubMed ID: 9016471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tracheal aspirate surface tension in babies with hyaline membrane disease: effects of synthetic surfactant replacement.
    McMillan DD; Singhal N; Shukla AK; Schürch S
    Pediatr Pulmonol; 1998 Sep; 26(3):173-82. PubMed ID: 9773912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Outcome of blood gas parameters during the first 24 years after Exosurf administration].
    Lenoir S; Grandjean H; Claris O; Hascoët JM
    Arch Pediatr; 1996 Apr; 3(4):324-8. PubMed ID: 8762952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional residual capacity (FRC) does not predict response to surfactant in preterm infants.
    Dermendjian M; Varma S; Krauss AN; Auld PA
    Am J Perinatol; 2002 Apr; 19(3):155-62. PubMed ID: 12012291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of synthetic and natural surfactant on fluid balance in acute respiratory distress syndrome.
    Murdoch E; Kempley ST
    Eur J Pediatr; 2000 Oct; 159(10):767-9. PubMed ID: 11039133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
    Levine D; Edwards DK; Merritt TA
    AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Artificial versus natural surfactant--can we base clinical practice on a firm scientific footing?
    Tarnow-Mordi WO; Soll RF
    Eur J Pediatr; 1994; 153(9 Suppl 2):S17-21. PubMed ID: 7957438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ventilation-perfusion relationships in preterm infants after surfactant treatment.
    Bowen W; Martin CR; Krauss AN; Auld PA
    Pediatr Pulmonol; 1994 Sep; 18(3):155-62. PubMed ID: 7800432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surfactant therapy in respiratory distress syndrome--the first local experience.
    Lim NL; Nordin MM; Cheah IG
    Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of a peptide-containing synthetic lung surfactant on gas exchange and lung mechanics in a rabbit model of surfactant depletion.
    van Zyl JM; Smith J; Hawtrey A
    Drug Des Devel Ther; 2013; 7():139-48. PubMed ID: 23507973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New-born infants with severe hyaline membrane disease: radiological evaluation during high frequency oscillatory versus conventional ventilation.
    Helbich TH; Popow C; Dobner M; Wunderbaldinger P; Zekert M; Herold CJ
    Eur J Radiol; 1998 Oct; 28(3):243-9. PubMed ID: 9881260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulmonary effects after surfactant treatment in premature infants with severe respiratory distress syndrome.
    Farstad T; Bratlid D
    Biol Neonate; 1995; 68(4):246-53. PubMed ID: 8580215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lung gas volumes and expiratory time constant in immature newborn rabbits treated with natural or synthetic surfactant or detergents.
    Bongrani S; Fornasier M; Papotti M; Razzetti R; Robertson B
    Biol Neonate; 1994; 65(6):406-15. PubMed ID: 8043702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spiking Survanta with synthetic surfactant peptides improves oxygenation in surfactant-deficient rats.
    Walther FJ; Hernández-Juviel J; Bruni R; Waring AJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):855-61. PubMed ID: 9310004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.